Devianee (Devi) Swain Lenz, PhD, is the Director of the Duke Sequencing and Genomics Technologies Core Facility (SGT) and has over 15 years of experimental and computational experience in genomics research. She earned her PhD in Molecular Genetics and Genomics at Washington University in St. Louis and completed her postdoctoral research at Duke University. Her research interests focus on understanding how cis-regulatory variation contributes to phenotypic differences between and within species. She has also held multiple leadership roles for nonprofit organizations whose emphasis is on increasing and maintaining diversity, equity, and inclusion in STEM-related fields.

Shu Boles holds a PhD in developmental biology from Washington University in St. Louis and completed her postdoctoral training at UC San Diego. She also holds an MBA from UC San Diego – Rady School of Management. Shu has extensive experience in next-generation sequencing in research applications, especially cancer research and clinical oncology. In 2022, Shu joined QIAGEN as Director of Genomics Strategic Marketing.

Shawn Prince is a Field Application Scientist with QIAGEN Digital Insights. Shawn is based in Pennsylvania and has been with QIAGEN since 2006, starting his bioinformatics journey with CLC bio, which QIAGEN acquired in 2013. His primary bioinformatics focus is on DNA and RNA secondary and tertiary analysis workflows, as well as scalable enterprise solutions.

Dr. Samuel Rulli received his PhD in Molecular and Cellular Biology from Tulane University in 2002, studying the gastric proton pump. After his postdoctoral training at Johns Hopkins University and the National Cancer Institute, he joined QIAGEN in 2009. As the Associate Director of Global Product Management for NGS technologies, Samuel has been instrumental in developing gene expression analysis solutions for qPCR and NGS.